FindTrial
Sign In

Blood Volume Measurement using HES injection, and Noninvasive Cardiac Output Measurement to Assess Hemodynamic Responses During Elective Cesarean Section.

Blood Volume Measurement using HES injection, and Noninvasive Cardiac Output Measurement to Assess Hemodynamic Responses During Elective Cesarean Section. - HES injection study

Status
Unknown
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON46850
Enrollment
158
Registered
2018-01-25
Start date
Unknown
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hemodynamiek cesarean section surgical birth

Interventions

cesarean section
hemodynamic responses
HES injection
non invasive cardiac output monitoring

Sponsors

Medisch Universitair Ziekenhuis Maastricht
Lead Sponsor

Eligibility

Age
18 Years to 64 Years

Inclusion criteria

Inclusion criteria: -pregnant women scheduled for elective cesarean section -over 18 years of age -singleton pregnancy -agree to participate in the study -mastery of the Dutch language

Exclusion criteria

Exclusion criteria: -under 18 years of age -multiple pregnancy -cardiac disease: pump failure, congenital defects with ongoing hemodynamic effects (valve dysfunction) -refusal to participate in the study

Design outcomes

Primary

MeasureTime frame
Primary endpoint is severe hypotension, defined as either a decline in blood pressure of 20% ore more from the baseline, or a systolic blooed pressure below 100 mmHg.—

Secondary

MeasureTime frame
Secondary enpoints will be the relative changes in cardiac output during volume resuscitation.—

Countries

Israel

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)